Raltegravir
CAS No. 518048-05-0
Raltegravir ( MK-0518;MK 0518;MK0518 )
Catalog No. M14807 CAS No. 518048-05-0
A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 34 | In Stock |
|
5MG | 52 | In Stock |
|
10MG | 95 | In Stock |
|
25MG | 173 | In Stock |
|
50MG | 286 | In Stock |
|
100MG | 426 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRaltegravir
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.
-
DescriptionA potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM; essentially inactive (IC50s>50 uM) against HCV Pol, HIV RT, HIV RNase-H, and human α/β/γ Pol; shows inhibitory activity against the wild type virus and a selection of mutants; the first HIV-integrase inhibitor for the treatment of HIV-1 infection.HIV Infection Approved
-
SynonymsMK-0518;MK 0518;MK0518
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorIntegrase(S217QPFV);Integrase(WTPFV)
-
Research AreaInfection
-
IndicationHIV Infection
Chemical Information
-
CAS Number518048-05-0
-
Formula Weight444.42
-
Molecular FormulaC20H21FN6O5
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F
-
Chemical Name4-Pyrimidinecarboxamide, N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Summa V, et al. J Med Chem. 2008 Sep 25;51(18):5843-55.
2. Malet I, et al. Antimicrob Agents Chemother. 2008 Apr;52(4):1351-8.
3. Cooper DA, et al. N Engl J Med. 2008 Jul 24;359(4):355-65.
2. Malet I, et al. Antimicrob Agents Chemother. 2008 Apr;52(4):1351-8.
3. Cooper DA, et al. N Engl J Med. 2008 Jul 24;359(4):355-65.
molnova catalog
related products
-
I-XW-053
I-XW-053 is an inhibitor of capsid targeted HIV-1 replication using the hybrid structure based method to block the interface between CA N-terminal domains (NTD-NTD interface) with micromolar affinity.
-
HIV-1 Integrase Inhi...
HIV-1 Integrase Inhibitor 7 is an allosteric HIV-1 integrase inhibitor that inhibits the LEDGF/p75-integrase interaction.
-
Nevirapine
A potent and specific non-nucleoside inhibitor (NNRTI) of HIV-1 reverse transcriptase with Ki of 0.2 uM.